prednisolone has been researched along with Cognitive Decline in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures." | 3.91 | A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions. ( Kishida, D; Miyazaki, D; Sato, M; Sekijima, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Teo, R | 1 |
| Dhanasekaran, P | 1 |
| Tay, SH | 1 |
| Mak, A | 1 |
| Sato, M | 1 |
| Kishida, D | 1 |
| Miyazaki, D | 1 |
| Sekijima, Y | 1 |
| Khan, MA | 1 |
| Garg, K | 1 |
| Bhurani, D | 1 |
| Agarwal, NB | 1 |
1 trial available for prednisolone and Cognitive Decline
| Article | Year |
|---|---|
Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cognition; Cognitive Dysfunction; | 2016 |
2 other studies available for prednisolone and Cognitive Decline
| Article | Year |
|---|---|
Mathematical processing is affected by daily but not cumulative glucocorticoid dose in patients with systemic lupus erythematosus.
Topics: Adult; Cognitive Dysfunction; Correlation of Data; Dose-Response Relationship, Drug; Female; Glucoco | 2020 |
A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions.
Topics: Administration, Intravenous; Anti-Inflammatory Agents; Autoantibodies; Brain; Cognitive Dysfunction; | 2019 |